Dr L’Erario discusses neurologic care for TGD patients, highlighting key challenges, best practices, & steps toward more ...

For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety ...

HealthDay News — Opportunities remain to increase use of the 988 Suicide and Crisis Lifeline, according to a research letter published online June 9 in JAMA Network Open.

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

Decreases in global cognition and executive function, as well as long-term persistent declines in those cognitive domains, are associated with incident HF.

The FDA has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.

Neurosteroids demonstrate significant therapeutic promise through the modulation of the GABA system and warrant further investigation.

Certain objectively measured daytime napping behaviors are associated with an increased risk for mortality for middle- to older-aged adults.

The FDA has accepted for review the resubmitted NDA for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease.